Nakagawa Shinsaku | Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University
スポンサーリンク
概要
- Nakagawa Shinsakuの詳細を見る
- 同名の論文著者
- Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka Universityの論文著者
関連著者
-
Nakagawa S
Graduate School Of Pharmaceutical Sciences Osaka University
-
Nakagawa Shinsaku
中華人民共和国
-
Tsutsumi Y
Dep. Of Toxicology And Safety Sci. Graduate School Of Pharmaceutical Sciences Osaka Univ.
-
村上 智彦
神戸学院大学 薬
-
Nakagawa S
Osaka Univ. Osaka Jpn
-
提 康央
Faculty Of Pharmaceutical Sciences Osaka University
-
真弓 忠範
Graduate School Of Pharmaceutical Sciences Kobe-gakuin Univ.
-
Tsujino Masaki
大阪大学 薬学研究科薬剤学
-
Nakagawa Shinsaku
Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka Univ
-
Nakagawa Shinsaku
Faculty Of Pharmaceutical Sciences Osaka University
-
Nakagawa Shinsaku
Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
MAYUMI Tadanori
Faculty and Graduate School of Pharmaceutical Sciences, Osaka University
-
Yoshioka Yasuo
Department Of Radiation Oncology Osaka University Graduate School Of Medicine
-
Yoshioka Yasuo
大阪大学 医学系研究科放射線治療学
-
Yoshioka Yasuo
Dept. Of Radiation Oncology Osaka University Graduate School Of Medicine
-
真弓 忠範
大阪大学 薬 薬剤
-
Tsunoda S
Lab. Of Pharmaceutical Proteomics National Inst. Of Biomedical Innovation (nibio)
-
Mukai Yohei
Graduate School Of Pharmaceutical Sciences Osaka University
-
Mukai Yohei
医薬基盤研究所 創薬プロテオミクスプロジェクト
-
Sugita Toshiki
Lab. Of Pharmaceutical Proteomics National Inst. Of Biomedical Innovation
-
Sugita Toshiki
医薬基盤研究所 創薬プロテオミクスプロジェクト
-
Sugita Toshiki
Department Of Biopharmaceutics Graduate School Of Pharmaceutical Sciences Osaka University
-
Morishita Yuki
Dep. Of Toxicology And Safety Sci. Graduate School Of Pharmaceutical Sciences Osaka Univ.
-
Morishita Yuki
大阪大学 薬学研究科毒性学
-
前田 光子
Life Science Center Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
TSUTSUMI Yasuo
Faculty and Graduate School of Pharmaceutical Sciences, Osaka University
-
川崎 紘一
Life Science Center Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Maeda M
Department Of Pharmacology Faculty Of Pharmaceutical Sciences Nagasaki University:faculty Of Pharmac
-
Kiwada Hiroshi
Faculty Of Pharmaceutifal Sciences The University Of Tokushima
-
MAYUMI Tadanori
Department of Cell Therapeutics, Graduate School of Pharmaceutical Sciences, Kobe Gakuin University
-
Shibata Hiroko
Laboratory Of Pharmaceutical Proteomics National Institute Of Biomedical Innovation (nibio)
-
Shibata Hiroko
医薬基盤研究所 創薬プロテオミクスプロジェクト
-
Higashisaka Kazuma
Dep. Of Toxicology And Safety Sci. Graduate School Of Pharmaceutical Sciences Osaka Univ.
-
Kamada Haruhiko
医薬基盤研究所 創薬プロテオミクスプロジェクト
-
Kamada Haruhiko
Laboratory Of Pharmaceutical Proteomics (lpp) National Institute Of Biomedical Innovation (nibio)
-
Maeda Mitsuko
Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Kiwada Hiroshi
Department Of Pharmacokinetics And Biopharmaceutics Faculty Of Pharmaceutical Sciences The Universit
-
Kamiya Hiroyuki
Lab. For Molecular Design Of Pharmaceutics Fac. Of Pharmaceutical Sciences Hokkaido Univ.
-
Kiwada Hiroshi
徳島大学 ヘルスバイオサイエンス研究部薬物動態制御学
-
GAO Jian-Qing
College of Pharmaceutical Sciences, Zhejiang University
-
NAKAGAWA Shinsaku
Graduate School of Pharmaceutical Sciences, Osaka University
-
Gao Jian-qing
College Of Pharmaceutical Sciences Zhejiang University
-
Yu Jian-heng
Affiliated First Hospital Zhejiang University
-
Gao Jian-qing
College Of Pharmaceutical Sciences Zhejiang University:graduate School Of Pharmaceutical Sciences Os
-
Okada Naoki
Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka Univ
-
Kawai Y
Faculty Of Pharmaceutical Sciences Kobe-gakuin University
-
Kawai Yuichi
Graduate School Of Pharmaceutical Sciences Kobe-gakuin Univ.
-
Tsutsumi Yasuo
Department Of Electrical Engineering Akashi College Of Technology
-
Gao J‐q
College Of Pharmaceutical Sciences Zhejiang University
-
Abe Yasuhiro
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Tsutsumi Yasuo
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka Unive
-
TSUNODA Shin-ichi
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
Abe Yasuhiro
Lab. Of Pharmaceutical Proteomics National Inst. Of Biomedical Innovation (nibio)
-
Abe Yasuhiro
医薬基盤研究所 創薬プロテオミクスプロジェクト
-
Keiko Hojo
Life Science Center Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Miyamoto H
Osaka Univ. Osaka
-
Yoshioka Yasuo
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka Unive
-
Kamada Haruhiko
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Mayumi Tadanori
Graduate School of Pharmaceutical Sciences, Kobe-Gakuin University
-
Mukai Yohei
Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka Univ
-
Eto Yusuke
Department Of Biotechnology And Therapeutics Graduate School Of Pharmaceutical Sciences Osaka Univer
-
Eto Yusuke
大阪大学 薬研究
-
SHIBATA Hiroko
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
GAO Jian-Qing
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
Nomura Tetsuya
Graduate School Of Pharmaceutical Sciences Osaka University
-
Nomura Tetsuya
Graduate School Of Pharmaceutical Sciences Kumamoto University
-
Imai Sunao
Laboratory Of Pharmaceutical Proteomics National Institute Of Biomedical Innovation:department Of Bi
-
Nagano Kazuya
Lab. Of Pharmaceutical Proteomics National Inst. Of Biomedical Innovation (nibio)
-
Nagano Kazuya
医薬基盤研究所 創薬プロテオミクスプロジェクト
-
Imazu Susumu
Department Of Biopharmaceutics Graduate School Of Pharmaceutical Sciences Osaka University
-
Imazu Susumu
大阪大学 薬学研究科薬剤学
-
OKADA Naoki
Faculty of Graduate School of Pharmaceutical Sciences, Osaka University
-
Hojo Keiko
Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Nagano Kazuya
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Yoshikawa Tomoaki
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka Unive
-
OKAMOTO Takayuki
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
NOMURA Tetsuya
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
MUKAI Yohei
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
SUGITA Toshiki
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
IMAI Sunao
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
TSUTSUMI Yasuo
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
TSUTSUMI Yasuo
National Institute of Biomedical Innovation
-
HAYAKAWA Takao
National Institute of Health Sciences
-
TSUTSUMI Yasuo
Graduate School of Pharmaceutical Sciences, Osaka University
-
Imai Sunao
医薬基盤研究所 創薬プロテオミクスプロジェクト
-
MIYAMOTO Hajime
Faculty and Graduate School of Pharmaceutical Sciences, Osaka University
-
Eto Yusuke
Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka Univ
-
Mizuguchi Hiroyuki
Department of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka
-
Eto Yusuke
Graduate School Of Pharmaceutical Sciences Osaka University
-
YAMAMOTO Yoko
Department of Materials Science and Engineering,Graduate School of Engineering,Osaka University
-
KIDA Shinya
Life Science Center, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
MAYUMI Tadanori
Kobegakuin University
-
YAMAMOTO Akira
Department of Biopharmaceutics, Kyoto Pharmaceutical University
-
SUGITA Toshiki
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
LIANG Wen-Quan
College of Pharmaceutical Sciences, Zhejiang University
-
MUKAI Yohei
Graduate School of Pharmaceutical Sciences, Osaka University
-
TANIAI Madoka
Hayashibara Biochemical Laboratories, Inc.
-
Akashi Mitsuru
School Of Chemical And Material Engineering Southern Yangtze University
-
Akashi M
Creation Of Bio-devices And Bio-systems With Chemical And Biological Molecules For Medical Use"
-
Akashi Mitsuru
Osaka Univ. Suita Jpn
-
KIHIRA Tetsuya
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
TSUNODA Shin-ichi
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
WAKAI Yukiko
Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
-
KOIZUMI Keiichi
Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
-
YOSHIOKA Tatsunobu
Faculty and Graduate School of Pharmaceutical Sciences, Osaka University
-
SUZUKI Ryo
Faculty and Graduate School of Pharmaceutical Sciences, Osaka University
-
KATSUME Asao
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co.
-
SAITO Hiroyuki
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co.
-
KUBO Kazuyoshi
Faculty and Graduate School of Pharmaceutical Sciences, Osaka University
-
OHSUGI Yoshiyuki
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co.,
-
Kihira Tetsuya
Department Of Biopharmaceutics Graduate School Of Pharmaceutical Sciences Osaka University
-
Kihira Tetsuya
大阪大学 薬研究薬剤学
-
Suzuki Ryo
Graduate School Of Pharmaceutical Sciences Nagoya City Univ.
-
Hu Ying
Institute Of Pharmaceutics College Of Pharmaceutical Sciences Zhejiang University:department Of Phar
-
Kida Shinya
Life Science Center Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Wakai Yukiko
Department Of Biopharmaceutics School Of Pharmaceutical Sciences Osaka University
-
Katsume A
Fuji-gotemba Research Laboratories Chugai Pharmaceutical Co.
-
Liang Wen-quan
College Of Pharmaceutical Sciences Zhejiang University
-
Sato Masao
Department Of Legal Medicine Fukushima Medical University School Of Medicine
-
Sato Masao
Laboratory Of Pharmaceutical Proteomics National Institute Of Biomedical Innovation:department Of Bi
-
Ishida Tatsuhiro
Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Inst
-
Yao Xinglei
Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka Univ
-
Morishige Tomohiro
Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka Univ
-
Narimatsu Shogo
Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka Univ
-
Kiwada Hiroshi
Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Inst
-
Sato Masao
Faculty of Pharmaceutical Science, Tokushima Bunri University
-
Han Min
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University
-
Chen Jin-Liang
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University
-
Hu Ying
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University
-
He Cai-Li
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University
-
Shuai Wu-Ping
Affiliated First Hospital, Zhejiang University
-
Yu Jian-Heng
Affiliated First Hospital, Zhejiang University
-
Chen Hai-Liang
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University
-
Liang Wen-Quan
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University
-
Mayumi Tadanori
Kobe-gakuin University
-
Gao Jian-Qing
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University
-
ASAVATANABODEE Ratima
Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka Univ
-
MAEDA Mitsuko
Life Science Center, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
HOJO Keiko
Life Science Center, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
TSUDA Yuko
Life Science Center, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
MAYUMI Tadanori
Life Science Center, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
KAWASAKI Koichi
Life Science Center, Faculty of Pharmaceutical Sciences, Kobe Gakuin University
-
KAWAMURA Maki
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
OHKAWA Akiko
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
SATO Masaki
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
IMAZU Susumu
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
HAYASHI Kazuyuki
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
TSUDA Yasuhiro
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
AKASHI Mitsuru
"Creation of bio-devices and bio-systems with chemical and biological molecules for medical use", CR
-
TSUJINO Masaki
Department of Biopharmaceutics, Kyoto Pharmaceutical University
-
HAYASHI Akira
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
GAO Jian
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
KANAGAWA Naoko
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
IIDA Keisuke
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
NAKAYAMA Takashi
Department of Microbiology, Kinki University School of Medicine
-
YOSHIE Osamu
Department of Microbiology, Kinki University School of Medicine
-
Chen Jin-liang
College Of Pharmaceutical Sciences Zhejiang University
-
Han Min
College of Pharmaceutical Sciences, Zhejiang University
-
近藤 昌夫
Graduate School Of Pharmaceutical Sciences Osaka University:department Of Pharmaceutics And Biopharm
-
NAKAMURA Teruya
Graduate School of Pharmaceutical Sciences, Kumamoto University
-
YOSHIOKA Yasuo
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
OHTA Tsunetaka
Hayashibara Biochemical Laboratories, Inc.
-
YAMAGATA Yuriko
Graduate School of Pharmaceutical Sciences, Kumamoto University
-
YAMATO Tomoko
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
YAMANADA Natsue
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation
-
Yamanada Natsue
Laboratory Of Pharmaceutical Proteomics National Institute Of Biomedical Innovation:department Of Bi
-
TAKAHASHI Koichi
Department of Biology, McGill University
-
Saito Hiroyuki
Department of Biophysical Chemistry, Kobe Pharmaceutical University
-
Akashi Mitsuru
Department Of Applied Chemistry And Chemical Engineering Faculty Of Engineering Kagoshima University
-
Tsujino Masaki
Department Of Biopharmaceutics Kyoto Pharmaceutical University
-
SHIBATA Hiroko
Graduate School of Pharmaceutical Sciences, Osaka University
-
KAMADA Haruhiko
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
SHIBATA Hiroko
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
TANIAI Madoka
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
SHIMIZU Tomoe
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
KAWAMURA Maki
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
ABE Yasuhiro
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
MATSUI Junji
Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
-
MAKIMOTO Hiroo
Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
-
OHIZUMI Iwao
Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai and Pharmaceutical Co
-
TANIGUCHI Kenji
Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai and Pharmaceutical Co
-
KAIHO Shin-ichi
Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai and Pharmaceutical Co
-
UTOGUCHI Naoki
Showa College of Pharmaceutical Sciences, 3-3165 Higashi Tamagawa Gakuen
-
OHSUGI Yoshiyuki
Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai and Pharmaceutical Co
-
SAKAMOTO Kayoko
Faculty and Graduate School of Pharmaceutical Sciences, Osaka University
-
YOROZU Keigo
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co.
-
UEDA Otoya
Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co.
-
Smith Timothy
School Of Pharmacy University Of Pacific
-
Shimizu Tomoe
Department Of Biopharmaceutics Graduate School Of Pharmaceutical Sciences Osaka University
-
近藤 昌夫
Graduate School Of Pharmaceutical Sciences Osaka Univ.
-
HAYAKAWA Takao
Division of Biological Chemistry and Biologicals, National Institute of Health Sciences
-
FUJITA Takuya
Department of Biopharmaceutics, Kyoto Pharmaceutical University
-
He Cai-li
College Of Pharmaceutical Sciences Zhejiang University
-
SHIMOKAWA Mariko
CREST (Core Research for Evolutional Science and Technology) of Japan Science and Technology Corpora
-
ODA Atsushi
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
NIWA Takako
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University
-
Han Min
College Of Pharmaceutical Sciences Zhejiang University
-
Tsuda Yuko
Life Science Center Faculty Of Pharmaceutical Sciences Kobe Gakuin University
-
Ohizumi Iwao
Department Of Cancer Research Fuji Gotemba Research Laboratories Chugai And Pharmaceutical Co
-
Shuai Wu-ping
Affiliated First Hospital Zhejiang University
著作論文
- Optimized PEGylated Adenovirus Vector Reduces the Anti-vector Humoral Immune Response against Adenovirus and Induces a Therapeutic Effect against Metastatic Lung Cancer
- In Vitro and In Vivo Tumor Suppressive Activity Induced by Human Telomerase Transcriptase-Targeting Antisense Oligonucleotides Mediated by Cationic Liposomes(CELL AND TISSUE ENGINEERING)
- Cell-Penetrating Peptides as Adenovirus Vector Carrier
- Creation of Novel Cell-Penetrating Peptides for Intracellular Drug Delivery Using Systematic Phage Display Technology Originated from Tat Transduction Domain(Biochemistry)
- Non-Methylated CpG Motif Packaged into Fusogenic Liposomes Enhance Antigen-Specific Immunity in Mice(Highlighted paper selected by Editor-in-chief,Pharmacology)
- Vaccine Efficacy of Fusogenic Liposomes Containing Tumor Cell-Lysate against Murine B16BL6 Melanoma(Pharmacology)
- Anti-tumor Responses Induced by Chemokine CCL19 Transfected into an Ovarian Carcinoma Model via Fiber-Mutant Adenovirus Vector(Biopharmacy)
- Fusogenic Liposome can be Used as an Effective Vaccine Carrier for Peptide Vaccination to Induce Cytotoxic T Lymphocyte (CTL) Response(Biopharmacy)
- Fast Binding Kinetics and Conserved 3D Structure Underlie the Antagonistic Activity of Mutant TNF : Useful Information for Designing Artificial Proteo-Antagonists
- Creation of Novel Protein Transduction Domain (PTD) Mutants by a Phage Display-Based High-Throughput Screening System(Biochemistry)
- Quality Enhancement of the Non-immune Phage scFv Library to Isolate Effective Antibodies(Highlighted paper selected by Editor-in-chief,Biochemistry)
- Development of Novel Drug Delivery System (DDS) Technologies for Proteomic-Based Drug Development
- Selective Enhancer of Tumor Vascular Permeability for Optimization of Cancer Chemotherapy (Pharmacognosy)
- Effective Cancer Targeting Using an Anti-tumor Tissue Vascular Endotheliumm specific Monoclonal Antibody (TES-23)
- Prolongation of the Effective Duration of Cytomedical Therapy by Re-injecting SK2 Hybridoma Cells Microencapsulated within Alginate-Poly(L)lysine-Alginate Membranes into Human Interleukin-6 Transgenic Mice
- Therapeutic Effect of Cytomedicine on Mesangio-Proliferative Glomerulonephritis in Human Interleukin-6 Transgenic Mice
- Neutralizing Antibody Evasion Ability of Adenovirus Vector Induced by the Bioconjugation of Methoxypolyethylene Glycol Succinimidyl Propionate(MPEG-SPA)(Biopharmacy)
- Anti-angiogenic Effects of Dimethyl Sulfoxide on Endothelial Cells(Pharmacognosy)
- Preparation and Biological Activities of a Bivalent Poly(Ethylene Glycol) Hybrid Containing an Active Site and Its Synergistic Site of Fibronectin
- Tumor Necrosis Factor α-Gene Therapy for an Established Murine Melanoma Using RGD (Arg-Gly-Asp) Fiber-mutant Adenovirus Vectors
- 3P-081 ファージ表面提示法を用いたTNFR1指向性リンフォトキシンαの創製とその特性評価(蛋白質工学,進化工学,第46回日本生物物理学会年会)
- Evaluation of Angiogenic Inhibitors with an in vivo Quantitative Angiogenesis Method Using Agarose Microencapsulation and Mouse Hemoglobin Enzyme-linked Immunosorbent Assay
- Selective Enhancement by Tumor Necrosis Factor-α of Vascular Permeability of New Blood Vessels Induced with Agarose Hydrogel-entrapped Meth-A Fibrosarcoma Cells
- A Quantitative in vivo Method of Analyzing Human Tumor-induced Angiogenesis in Mice Using Agarose Microencapsulation and Hemoglobin Enzyme-linked Immunosorbent Assay
- Studies on Heterobifunctional Cross-Linking Reagents, 6-Maleimidohexanoic Acid Active Esters
- Preparation and Characterization of Liposomes Encapsulating Chitosan Nanoparticles(Biopharmacy)
- Amino Acids and Peptides.XXXVIII.Facile Synthesis of Laminin-Related Peptide-Poly(Ethylene Glycol)Hybrids by the Solid Phase Method
- Growth Inhibition of Human Leukemia HL-60 Cells by an Antisense Phosphodiester Oligonucleotide Encapsulated into Fusogenic Liposomes
- A Bivalent Poly (ethylene glycol) Hybrid Containing an Active Site (RGD) and a Synergistic Site of Fibronectin
- In vivo Anti-tumor Efficacy of Polyethylene Glycol-modified Tumor Necrosis Factor-α against Tumor Necrosis Factor-resistant Tumors
- Preferential Activity of Wild-type and Mutant Tumor Necrosis Factor-α against Tumor-derived Endothelial-like Cells
- Amino Acids and Peptides. XXXI. Preparation of Analogs of the Laminin-Related Peptide YIGSR and Their Inhibitory Effect on Experimental Metastasis
- Amino Acids and Peptides. XXX. Preparation of Arg-Gly-Asp (RGD) Hybrids with Poly(Ethylene Glycol) Analogs and Their Antimetastatic Effect
- Amino Acids and Peptides. XXIX. Synthesis and Antimetastatic Effects of Peptides and Peptide-Poly(Ethylene Glycol) Hybrids Related to the Core Sequence of the Type III Connecting Segment Domain of Fibronectin
- Preparation of Laminin-related Peptide Analogs and Their Inhibitory Effect on Experimental Metastasis in Mice
- Enhanced in Vitro Percutaneous Penetration of Salicylate by Ion Pair Formation with Alkylamines
- Isolation and Properties of Tumor-derived Endothelial Cells from Rat KMT-17 Fibrosarcoma
- Preparation of A Fibronectin-related Poly(Ethylene Glycol) Hybrid and Its Inhibitory Effect on Experimental Metastasis in Mice
- Modifying the antigen-immunization schedule improves the variety of monoclonal antibodies obtained from immune-phage antibody libraries against HIV-1 Nef and Vif(MEDICAL BIOTECHNOLOGY)